Hui Xiong
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery 12
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism 9
- MicroRNA in disease regulation 4
- Cancer-related molecular mechanisms research 4
- Transplantation top 10%
- Biomedical Engineering top 5%
- Nanoplatforms for cancer theranostics 17
-
- RNA Interference and Gene Delivery 5
- Circular RNAs in diseases 5
-
- Drug Transport and Resistance Mechanisms 4
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Hui Xiong
50 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 103
- Biomaterials 389
- Cancer Research 248
- Transplantation 42
- Biomedical Engineering 539
- Molecular Biology 615
Countries citing papers authored by Hui Xiong
This map shows the geographic impact of Hui Xiong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Xiong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Xiong more than expected).
Fields of papers citing papers by Hui Xiong
This network shows the impact of papers produced by Hui Xiong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Xiong. The network helps show where Hui Xiong may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hui Xiong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 1 | |
| 5 | 2025 | 0 | |
| 6 | 2024 | 25 | |
| 7 | 2024 | 5 | |
| 8 | 2024 | 5 | |
| 9 | 2024 | 6 | |
| 10 | 2023 | 16 | |
| 11 | 2023 | 12 | |
| 12 | 2022 | 7 | |
| 13 | 2021 | 8 | |
| 14 | 2021 | 78 | |
| 15 | 2021 | 15 | |
| 16 | 2021 | 42 | |
| 17 | 2020 | 36 | |
| 18 | 2019 | 88 | |
| 19 | 2018 | 47 | |
| 20 | 2014 | 3 |
About Hui Xiong
Hui Xiong is a scholar working on Cancer Research, Biomaterials and Biomedical Engineering, having authored 55 papers that have together received 1.4k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (17 papers), Nanoparticle-Based Drug Delivery (12 papers), Cancer, Hypoxia, and Metabolism (9 papers), RNA Interference and Gene Delivery (5 papers), Circular RNAs in diseases (5 papers), MicroRNA in disease regulation (4 papers), Cancer-related molecular mechanisms research (4 papers) and Drug Transport and Resistance Mechanisms (4 papers). The work is most often cited by research in Biomaterials (389 citations), Cancer Research (248 citations) and Transplantation (42 citations). Hui Xiong has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Jing Yao, Jianping Zhou, Shi Du, Ni Jiang, Zhijie Jiang, Zihan Wang, Jianping Zhou, Cheng Xu, Cheng Wang and Fatima Zohra Dahmani. Their work appears in journals such as Nano Letters, ACS Nano and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.